'CROSS'-ing into the 'Real World': a retrospective cohort study of patients receiving trimodality and bimodality therapy for esophageal cancer.
Saved in:
| Title: | 'CROSS'-ing into the 'Real World': a retrospective cohort study of patients receiving trimodality and bimodality therapy for esophageal cancer. |
|---|---|
| Authors: | Higgins LM; University of Vermont Larner College of Medicine, Burlington, VT, USA., Lester-Coll NH; Division of Radiation Oncology, University of Vermont Larner College of Medicine, Burlington, VT, USA.; University of Vermont Cancer Center, Burlington, VT, USA., Ades S; University of Vermont Cancer Center, Burlington, VT, USA.; Department of Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA., Barry MM; University of Vermont Cancer Center, Burlington, VT, USA.; Department of Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA., Borrazzo EC; Department of Surgery, University of Vermont Larner College of Medicine, Burlington, VT, USA., Ganguly EK; Division of Gastroenterology and Hepatology, University of Vermont Larner College of Medicine, Burlington, VT, USA., Anker CJ; Division of Radiation Oncology, University of Vermont Larner College of Medicine, Burlington, VT, USA.; University of Vermont Cancer Center, Burlington, VT, USA. |
| Source: | Journal of gastrointestinal oncology [J Gastrointest Oncol] 2023 Apr 29; Vol. 14 (2), pp. 480-493. Date of Electronic Publication: 2023 Apr 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: AME Publishing Group Country of Publication: China NLM ID: 101557751 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2078-6891 (Print) Linking ISSN: 20786891 NLM ISO Abbreviation: J Gastrointest Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
